Krahn MD - Search Results

1

Significance of the CAG repeat polymorphism of the androgen receptor gene in prostate cancer progression.

Nam RK, Elhaji Y, Krahn MD, Hakimi J, Ho M, Chu W, Sweet J, Trachtenberg J, Jewett MA, Narod SA. Nam RK, et al. Among authors: krahn md. J Urol. 2000 Aug;164(2):567-72. J Urol. 2000. PMID: 10893645

2

Screening for prostate cancer. A decision analytic view.

Krahn MD, Mahoney JE, Eckman MH, Trachtenberg J, Pauker SG, Detsky AS. Krahn MD, et al. JAMA. 1994 Sep 14;272(10):773-80. JAMA. 1994. PMID: 7521400

3

Prostate cancer: 2. Natural history.

Nam RK, Jewett MA, Krahn MD. Nam RK, et al. Among authors: krahn md. CMAJ. 1998 Sep 22;159(6):685-91. CMAJ. 1998. PMID: 9780970 Free PMC article. Review. No abstract available.

4

Prostate specific antigen response to mitoxantrone and prednisone in patients with refractory prostate cancer: prognostic factors and generalizability of a multicenter trial to clinical practice.

Dowling AJ, Czaykowski PM, Krahn MD, Moore MJ, Tannock IF. Dowling AJ, et al. Among authors: krahn md. J Urol. 2000 May;163(5):1481-5. J Urol. 2000. PMID: 10751862

5

Construction of the Patient-Oriented Prostate Utility Scale (PORPUS): a multiattribute health state classification system for prostate cancer.

Krahn M, Ritvo P, Irvine J, Tomlinson G, Bezjak A, Trachtenberg J, Naglie G. Krahn M, et al. J Clin Epidemiol. 2000 Sep;53(9):920-30. doi: 10.1016/s0895-4356(00)00211-0. J Clin Epidemiol. 2000. PMID: 11004418

6

The ten-year rule revisited: accuracy of clinicians' estimates of life expectancy in patients with localized prostate cancer.

Krahn MD, Bremner KE, Asaria J, Alibhai SM, Nam R, Tomlinson G, Jewett MA, Warde P, Naglie G. Krahn MD, et al. Urology. 2002 Aug;60(2):258-63. doi: 10.1016/s0090-4295(02)01712-0. Urology. 2002. PMID: 12137823

7

Patient and community preferences for outcomes in prostate cancer: implications for clinical policy.

Krahn M, Ritvo P, Irvine J, Tomlinson G, Bremner KE, Bezjak A, Trachtenberg J, Naglie G. Krahn M, et al. Med Care. 2003 Jan;41(1):153-64. doi: 10.1097/00005650-200301000-00017. Med Care. 2003. PMID: 12544552

8

Delay in surgical therapy for clinically localized prostate cancer and biochemical recurrence after radical prostatectomy.

Nam RK, Jewett MA, Krahn MD, Robinette MA, Tsihlias J, Toi A, Ho M, Evans A, Sweet J, Trachtenberg J. Nam RK, et al. Among authors: krahn md. Can J Urol. 2003 Jun;10(3):1891-8. Can J Urol. 2003. PMID: 12892576

9

Do older men benefit from curative therapy of localized prostate cancer?

Alibhai SM, Naglie G, Nam R, Trachtenberg J, Krahn MD. Alibhai SM, et al. Among authors: krahn md. J Clin Oncol. 2003 Sep 1;21(17):3318-27. doi: 10.1200/JCO.2003.09.034. J Clin Oncol. 2003. PMID: 12947068

10

Continued undertreatment of older men with localized prostate cancer.

Schwartz KL, Alibhai SM, Tomlinson G, Naglie G, Krahn MD. Schwartz KL, et al. Among authors: krahn md. Urology. 2003 Nov;62(5):860-5. doi: 10.1016/s0090-4295(03)00690-3. Urology. 2003. PMID: 14624909

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

365 results

Search Page

Filters